Title:

Prophylactic Oral Application of Activated Charcoal Mitigates Acute Campylobacteriosis in Human Gut Microbiota-Associated IL-10−/− Mice

 

Objective: 

To evaluate the effect of activated charcoal in reducing symptoms of acute Campylobacteriosis in a mouse model with human gut microbiota.

 

Results: 

Activated charcoal significantly reduced the severity of Campylobacter infection by mitigating inflammation and restoring gut microbiota balance in IL-10−/− mice.

 

Conclusion:

Prophylactic use of activated charcoal may provide a potential therapeutic approach for managing Campylobacter infections by modulating gut microbiota and inflammation.


Full study can be found HERE